Inventor · disambiguated record
Richard Gregory
Also filed as: GREGORY RICHARD · GREGORY RICHARD J · GREGORY RICHARD JOSEPH · GREGORY RICHARD L
25 granted patents·33 pending applications·1,442 citations·filing 1993–2008
97Inventor score
Top patents by PatentIndex Score
58 records- 0197US5882877AAdenoviral vectors for gene therapy containing deletions in the adenoviral genomeGENZYME CORP·Filed 1997·Granted Mar 16, 1999·338 cites·21 claims
- 0297US5670488AAdenovirus vector for gene therapyGENZYME CORP·Filed 1993·Granted Sep 23, 1997·358 cites·19 claims
- 0396US6432927B1Compositions and methods for inducing gene expressionGENZYME CORP·Filed 2000·Granted Aug 13, 2002·62 cites·31 claims
- 0494US5932210ARecombinant adenoviral vector and methods of useCANJI INC·Filed 1997·Granted Aug 3, 1999·151 cites·19 claims
- 0592US6020191AAdenoviral vectors capable of facilitating increased persistence of transgene expressionGENZYME CORP·Filed 1997·Granted Feb 1, 2000·127 cites·3 claims
- 0691US6210939B1Recombinant adenoviral vector and methods of useCANJI INC·Filed 1994·Granted Apr 3, 2001·71 cites·25 claims
- 0790US7053062B2Compositions and methods for inducing gene expressionGENZYME CORP·Filed 2002·Granted May 30, 2006·16 cites·24 claims
- 0887US5877011AChimeric adenoviral vectorsGENZYME CORP·Filed 1996·Granted Mar 2, 1999·82 cites·2 claims
- 0985US6100086ATransgene expression systemsGENZYME CORP·Filed 1997·Granted Aug 8, 2000·55 cites·15 claims
- 1078US5981714AAntibodies specific for cystic fibrosis transmembrane conductance regulator and uses thereforGENZYME CORP·Filed 1996·Granted Nov 9, 1999·53 cites·10 claims
- 1177US6989268B2Recombinant adenoviral vector and methods of useCANJI INC·Filed 2003·Granted Jan 24, 2006·5 cites·9 claims
- 1276US6093567AGene therapy for cystic fibrosisGENZYME CORP·Filed 1999·Granted Jul 25, 2000·29 cites·2 claims
- 1375US7318919B2Adenovirus vectors for gene therapyGENZYME CORP·Filed 2002·Granted Jan 15, 2008·3 cites·8 claims
- 1472US5981275ATransgene expression system for increased persistenceGENZYME CORP·Filed 1997·Granted Nov 9, 1999·27 cites·4 claims
- 1572US2007253932A1Recombinant adenoviral vectors and methods of useCANJI INC·Filed 2007·Application pending·0 cites
- 1671US2007128166A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2006·Application pending·0 cites
- 1769US6358507B1Transgene expression systemsGENZYME CORP·Filed 1999·Granted Mar 19, 2002·18 cites·17 claims
- 1867US2006039893A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 1965US2004266006A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2004·Application pending·0 cites
- 2065US2006099187A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 2164US2009082289A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2007·Application pending·0 cites
- 2264US2008299083A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2007·Application pending·0 cites
- 2364US2007009486A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2006·Application pending·0 cites
- 2464US2009088398A1Recombinant adenoviral vectors and methods of useCANJI INC·Filed 2008·Application pending·0 cites
- 2563US2008182807A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2006·Application pending·0 cites
- 2663US2004087027A1Recombinant adenoviral vector and methods of useCANJI INC·Filed 2003·Application pending·0 cites
- 2763US2006140910A1Recombinant adenoviral vectors and methods of useCANJI INC·Filed 2005·Application pending·0 cites
- 2862US7041284B2Recombinant adenoviral vector and method of useCANJI INC·Filed 1997·Granted May 9, 2006·13 cites·32 claims
- 2962US2007254357A1Gene therapy using replication competent targeted adenoviral vectorsCANJI INC·Filed 2007·Application pending·0 cites
- 3061US2007031381A1Recombinant adenoviral vector and method of useCANJI INC·Filed 2005·Application pending·0 cites
- 3161US2008175818A1Adenoviral vectors having a protein ix deletionCANJI INC·Filed 2007·Application pending·0 cites
- 3261US2006034804A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 3359US2006171925A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 3459US2006275261A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 3559US2006233759A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 3658US2005002906A1Gene therapy using replication competent targeted adenoviral vectorsFiled 2004·Application pending·0 cites
- 3757US6485720B2Transgene expression systemsGENZYME CORP·Filed 2001·Granted Nov 26, 2002·0 cites·12 claims
- 3857US2006127361A1Compositions and methods for inducing gene expressionGENZYME CORP·Filed 2006·Application pending·0 cites
- 3955US6331524B1Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapyGENZYME CORP·Filed 1997·Granted Dec 18, 2001·11 cites·4 claims
- 4055US2006127961A1Diagnostic assays for determination of dental caries susceptibilityGREGORY RICHARD L·Filed 2006·Application pending·0 cites
- 4153US2007053879A1Diagnostic and treatment methods involving the cystic fibrosis transmembrane regulatorGENZYME CORP·Filed 2006·Application pending·0 cites
- 4249US5876974AMethod for producing DNA encoding cystic fibrosis transmembrane conductance regulator (CFTR) protein in E. coliGENZYME CORP·Filed 1994·Granted Mar 2, 1999·7 cites·8 claims
- 4349US2002164782A1Adenovirus vectors for gene therapyFiled 2000·Application pending·0 cites
- 4448US2003113823A1Diagnostic assays for determination of dental caries susceptibilityFiled 2002·Application pending·0 cites
- 4547US2004143104A1Methods of treating diabetes and other blood sugar disordersFiled 2003·Application pending·0 cites
- 4645US2005107318A1Methods of treating diabetes and other blood sugar disordersFiled 2003·Application pending·0 cites
- 4744US2007259429A9Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2001·Application pending·0 cites
- 4843US6379927B1Retinoblastoma fusion proteinsCANJI INC·Filed 1999·Granted Apr 30, 2002·5 cites·11 claims
- 4941US2005031590A9Adenoviral vectors having a protein IX deletionFiled 2001·Application pending·0 cites
- 5040US6074850ARetinoblastoma fusion polypeptidesCANJI INC·Filed 1997·Granted Jun 13, 2000·3 cites·18 claims
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Richard Gregory files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →